NICE backs use of Forxiga in triple therapy for diabetes
The National Institute for Health and Care Excellence has now published final draft guidelines endorsing NHS use of AstraZeneca’s Forxiga for treating type II diabetes as part of a ‘triple therapy’.
Read More
